Overview
The actively managed fund invests worldwide in convertible bonds.
Convertible bonds combine the upside potential of equities and the defensive characteristics of bonds.
The investment objective is to take full advantage of the beneficial risk-return characteristics of the global convertible bond markets.
Foreign currencies are largely hedged versus the reference currency.
The portfolio manager is not tied to the benchmark in terms of investment selection or weight.
Benefits
Investors participate in some of the price gains when equity markets are rising, and benefit from the defensive characteristics of a bond investment in falling markets.
The portfolio's return potential is considerably increased using carefully selected convertible bonds, without incurring significant additional risk.
Risks
Features
| Product category |
Bond Convertibles |
| Product domicile |
Luxembourg
|
| Portfolio management |
UBS SA国际传谋 Switzerland AG, Zurich
|
| Fund management |
UBS SA国际传谋 (Europe) S.A., Luxembourg
|
| Custodian bank |
UBS Europe SE, Luxembourg Branch
|
| Representative for products established under foreign law |
UBS AG, Stockholm
|
| Regulation |
UCITS
|
| Legal form |
Unlimited
|
| Day of inception |
September 25, 2012
|
| Currency of account |
EUR
|
| Close of financial year |
May 31
|
| SFDR Classification |
Art.8
|
| Issue / redemption |
daily
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.67% p.a.
|
| Management fee |
0.52% p.a.
|
| Total expense ratio (TER) |
0.68% p.a.
|
| Minimum investment |
EUR 10,000,000.00
|
| Reference Index / Benchmark |
FTSE Global Convertible Index – Global Vanilla Hedged (hedged EUR)
|
| Cut-Off Time |
15:00h(CET)
|
| ISIN |
LU0396332057
|
| Bloomberg Ticker |
UBCGIA2 LX
|
| Telekurs Id |
UBCGIA2
|
Performance and Prices
Percentage growth
as of April 23, 2026| EUR(%) | |
| YTD | |
| 1M | |
| 3M | |
| 6M | |
| 1Y | 24.07 |
| 2Y | |
| 3Y | 36.59 |
| 5Y | 14.28 |
| ø p.a.5Y | 2.71 |
Current data
| Net asset value | 23.04.2026 | EUR 211.60 |
| High - last 12 months | 20.04.2026 | EUR 212.26 |
| Low - last 12 months | 25.04.2025 | EUR 173.69 |
| Last distribution | 06.08.2025 | EUR 1.48 |
| Assets of the unit class in mn | 23.04.2026 | EUR 57.47 |
| Total product assets in mn | 23.04.2026 | EUR 4,737.95 |
Structures
By the 10 largest positions (in %, as of March 31, 2026)
|
|
|
| EchoStar 3.875% 2030 | 2.03 |
| SK hynix 1.75% 2030 | 1.76 |
| Ping An Insurance 0.875% 2029 | 1.71 |
| Lumentum 1.5% 2029 | 1.66 |
| Zijin Mining Group 1% 2029 | 1.59 |
| Alibaba(GS) 0% 2027 | 1.38 |
| ENI 2.95% 2030 | 1.14 |
| BridgeBio Pharma 1.75% 2031 | 1.13 |
| Guardant Health 1.25% 2031 | 1.10 |
| Saipem 2.875% 2029 | 1.10 |
Fees
Distributions
|
Date of distribution
|
Pay date
|
Cps no.
|
Currency
|
Distribution
|
|
| 01.08.2025 | 06.08.2025 | 13 | EUR | 1.48 |
Sales Authorisations
Literature
|
Document type
|
Document Language
|
| Prospectus |
|
| Key Information Document |
|
| Past performance |
|
| Previous performance scenario |
|
| Statutes / Management regulations |
|
| ESG Disclosure |
|
| SFDR Pre-Contractual Annex |
|
|
Document type
|
Document Language
|
| Annual report |
|
| SFDR Periodic Report Annex |
|
| Semi-annual report |
|